Total Funding
85
65
Total FundingGrant raised
Growth Score
-5 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
106966
BrainChild Bio develops CAR-T cell therapies for pediatric brain tumors, focusing on DIPG.
- Michael Jensen: Founder, CSO
About the Company
BrainChild Bio is a clinical-stage biotechnology company focusing on pediatric brain tumors. The company leverages CAR-T cell technology to develop therapies for tumors in the central nervous system, with an initial focus on diffuse intrinsic pontine glioma (DIPG). BrainChild Bio's work builds on prior clinical testing at Seattle
Children's Hospital, aiming to provide innovative treatments for incurable brain cancers in children.
